BR0107932A - Composições, kits e métodos para saúde cardiovascular - Google Patents

Composições, kits e métodos para saúde cardiovascular

Info

Publication number
BR0107932A
BR0107932A BR0107932-8A BR0107932A BR0107932A BR 0107932 A BR0107932 A BR 0107932A BR 0107932 A BR0107932 A BR 0107932A BR 0107932 A BR0107932 A BR 0107932A
Authority
BR
Brazil
Prior art keywords
compositions
kits
methods
benefits
treating
Prior art date
Application number
BR0107932-8A
Other languages
English (en)
Inventor
Robert Joseph Sarama
Raymond Louis Niehoff
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR0107932A publication Critical patent/BR0107932A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçõES, KITS E MéTODOS PARA SAúDE CARDIOVASCULAR". A presente invenção refere-se às composições que compreendem: (a) um primeiro componente selecionado do grupo que consiste em L-arginina, seus polipeptídeos, seus sais aceitáveis, suas pró-formas e misturas destes.; e (b) um segundo componente selecionado do grupo que consiste em esteróis, estanóis, ésteres destes, poliésteres de ácido graxo de poliol e misturas destes. A presente invenção também refere-se aos kits que compreendem estas composições bem como métodos de usar as composições. As composições, kits e métodos aqui são úteis para fornecer benefícios gerais de saúde ao consumidor, particularmente benefícios cardiovasculares, benefícios de antimenopausa e/ou tratar disfunção sexual (particularmente, disfunção de ereção). Mais particularmente, as composições, kits e métodos aqui são úteis para fornecer benefícios cardiovasculares, incluindo diminuição do colesterol no consumidor, tratamento, prevenção e/ou inibição de doença cardíaca (por exemplo, aterosclerose, restenose, trombose) e, por exemplo, tratamento de outras condições tais como hipercolesterolemia, hipertensão, circulação deficiente e complicações associadas com diabetes.
BR0107932-8A 2000-01-28 2001-01-25 Composições, kits e métodos para saúde cardiovascular BR0107932A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17877800P 2000-01-28 2000-01-28
PCT/US2001/002382 WO2001054686A2 (en) 2000-01-28 2001-01-25 L-arginine in combination with other compounds for treating cardiovascular diseases

Publications (1)

Publication Number Publication Date
BR0107932A true BR0107932A (pt) 2003-02-18

Family

ID=22653913

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107932-8A BR0107932A (pt) 2000-01-28 2001-01-25 Composições, kits e métodos para saúde cardiovascular

Country Status (8)

Country Link
EP (1) EP1255545A2 (pt)
JP (1) JP2003520812A (pt)
CN (1) CN1396825A (pt)
AU (1) AU2001234548A1 (pt)
BR (1) BR0107932A (pt)
CA (1) CA2395446A1 (pt)
MX (1) MXPA02007247A (pt)
WO (1) WO2001054686A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010780A0 (fi) 2001-04-12 2001-04-12 Raisio Benecol Oy Parannetut koostumukset
US20030203854A1 (en) * 2002-04-23 2003-10-30 Ivo Pischel Composition for effecting serum cholesterol levels
FI20030610A0 (fi) * 2003-04-22 2003-04-22 Raisio Benecol Oy Syötävä tuote
JP4526467B2 (ja) * 2005-10-26 2010-08-18 アサヒビール株式会社 滋養強壮飲料
US7601380B2 (en) * 2005-11-17 2009-10-13 Pepsico, Inc. Beverage clouding system and method
FI20095146A (fi) 2009-02-18 2010-08-19 Valio Oy Menetelmä elintarvikevalmisteen maun parantamiseksi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157022A (en) * 1989-11-22 1992-10-20 Adrian Barbul Method for reducing blood cholesterol using arginine
DE19750422C1 (de) * 1997-11-14 1998-11-26 Henkel Kgaa Verwendung von ausgewählten Phytostenolestern zur Herstellung von hypocholesterinämischen Mitteln
DE19800812C2 (de) * 1998-01-12 2000-05-11 Juergen C Froelich Verbesserte orale Darreichungsformen von L-Arginin-HCl

Also Published As

Publication number Publication date
CA2395446A1 (en) 2001-08-02
AU2001234548A1 (en) 2001-08-07
WO2001054686A2 (en) 2001-08-02
CN1396825A (zh) 2003-02-12
JP2003520812A (ja) 2003-07-08
EP1255545A2 (en) 2002-11-13
WO2001054686A3 (en) 2002-05-02
MXPA02007247A (es) 2002-12-16

Similar Documents

Publication Publication Date Title
BR0107933A (pt) Compostos de arginina saborosos e seus usos para saúde cardiovascular
Koshiyama et al. Novel mechanism of intracellular calcium release in pituitary cells.
EA200700040A1 (ru) Ферментативный способ рафинирования масла гидратацией
ATE446370T1 (de) Öl, das brassicastanol enthält
BR0313240A (pt) Cicloalquenilaminas condensadas por heteroarila, acilas e seu uso como farmacêuticos
EA200602191A1 (ru) 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
ATE273992T1 (de) Konjugate von ascorbinsäure und phytosterolen oder phytostanolen und ihre verwendung zur behandlung von gefässkrankheiten
EA200100704A1 (ru) Комбинация для применения по сердечно-сосудистым показаниям
ATE333885T1 (de) Verwendung von sulodexid zur behandlung von reizdarm
DE69906719T2 (de) Phytosterol-zusammensetzungen
BR0111328A (pt) Composto, mistura, processos para a preparação e produção de um composto, composição farmacêutica, uso de um composto, e, método para o tratamento ou prevenção de complicações de trombose arterial em pacientes com doença de artéria coronária, cerebrovascular ou vascular periférica
NO20051110L (no) Acylerte arylsykloalkylaminer og deres anvedelse som farmasoytiske midler
BR9904162A (pt) 4-carboxiamino-2-metil-1,2,3,4-tetra-hidroquinolinas aneladas
BR0106178A (pt) Processo para produção de ésteres de ácidos graxos de esteróis dietéticos
BR0001672A (pt) Composição e método para redução da cocentração de colesterol lipoprotéico de baixa densidade
JPH06506909A (ja) 血清における高コレステロールレベルを低めるための物質及びその物質を調製するための方法
BR0107932A (pt) Composições, kits e métodos para saúde cardiovascular
ATE460394T1 (de) 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
BR0015331A (pt) Composições de esterol para a redução de colesterol, preparação e método de utilização
Ruiz et al. Kaempferol inhibits apoptosis in vascular smooth muscle induced by a component of oxidized LDL
Ghosh et al. Biodegradation of cytotoxic 7-Ketocholesterol by Pseudomonas aeruginosa PseA
Hammen et al. The role of positive charges and structural segments in the presequence of rat liver aldehyde dehydrogenase in import into mitochondria
PT865498E (pt) Processo para a preparacao de ciclodepsipeptideos com 24 atomos no anel substituidos contendo acido aril-lactico
BRPI0309421B8 (pt) método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
BR0311334A (pt) Sìntese de composições de poliéster de ácido graxo de poliol purificado, parcialmente esterificado

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 4A, 5A, 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.